Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Berridge CW, Waterhouse BD (2003). The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev 42: 33–84.
Bremner JD, Krystal JH, Southwick SM, Charney DS (1996). Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse 23: 28–38.
Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA et al (2007). Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 164: 1356–1363.
Grunhaus L, Pande AC, Brown MB, Greden JF (1994). Clinical characteristics of patients with concurrent major depressive disorder and panic disorder. Am J Psychiatry 151: 541–546.
Simson PE, Weiss JM (1988). Altered activity of the locus coeruleus in an animal model of depression. Neuropsychopharmacology 1: 287–295.
Walkup J, Labellarte M (2001). Complications of SSRI treatment. J Child Adolesc Psychopharmacol 11: 1–4.
Weiss JM, Boss-Williams KA, Moore JP, Demetrikopoulos MK, Ritchie JC, West CH (2005). Testing the hypothesis that locus coeruleus hyperactivity produces depression-related changes via galanin. Neuropeptides 39: 281–287.
Weiss JM, Stout JC, Aaron MF, Quan N, Owens MJ, Butler PD et al (1994). Depression and anxiety: role of the locus coeruleus and corticotropin-releasing factor. Brain Res Bull 35: 561–572.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Liberzon, I., George, S. SSRI-Enhanced Locus Coeruleus Activity and Adolescent Suicide: Lessons from Animal Models. Neuropsychopharmacol 35, 1619–1620 (2010). https://doi.org/10.1038/npp.2010.57
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2010.57